company background image
COLO B logo

Coloplast CPSE:COLO B Stock Report

Last Price

DKK 886.00

Market Cap

DKK 199.7b

7D

-1.6%

1Y

16.8%

Updated

05 Nov, 2024

Data

Company Financials +

COLO B Stock Overview

Engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally.

COLO B fundamental analysis
Snowflake Score
Valuation3/6
Future Growth3/6
Past Performance2/6
Financial Health1/6
Dividends3/6

Coloplast A/S Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Coloplast
Historical stock prices
Current Share PriceDKK 886.00
52 Week HighDKK 977.60
52 Week LowDKK 689.20
Beta0.33
11 Month Change2.71%
3 Month Change-1.42%
1 Year Change16.82%
33 Year Change-20.57%
5 Year Change11.87%
Change since IPO6,833.92%

Recent News & Updates

Coloplast (CPH:COLO B) Seems To Use Debt Quite Sensibly

Oct 18
Coloplast (CPH:COLO B) Seems To Use Debt Quite Sensibly

Recent updates

Coloplast (CPH:COLO B) Seems To Use Debt Quite Sensibly

Oct 18
Coloplast (CPH:COLO B) Seems To Use Debt Quite Sensibly

Coloplast A/S Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Aug 23
Coloplast A/S Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Are Investors Undervaluing Coloplast A/S (CPH:COLO B) By 38%?

Aug 22
Are Investors Undervaluing Coloplast A/S (CPH:COLO B) By 38%?

Subdued Growth No Barrier To Coloplast A/S' (CPH:COLO B) Price

Jul 17
Subdued Growth No Barrier To Coloplast A/S' (CPH:COLO B) Price

These 4 Measures Indicate That Coloplast (CPH:COLO B) Is Using Debt Reasonably Well

Jun 29
These 4 Measures Indicate That Coloplast (CPH:COLO B) Is Using Debt Reasonably Well

Coloplast's (CPH:COLO B) Solid Earnings May Rest On Weak Foundations

May 21
Coloplast's (CPH:COLO B) Solid Earnings May Rest On Weak Foundations

Coloplast (CPH:COLO B) Is Due To Pay A Dividend Of DKK5.00

May 10
Coloplast (CPH:COLO B) Is Due To Pay A Dividend Of DKK5.00

Analyst Estimates: Here's What Brokers Think Of Coloplast A/S (CPH:COLO B) After Its Interim Report

May 09
Analyst Estimates: Here's What Brokers Think Of Coloplast A/S (CPH:COLO B) After Its Interim Report

A Look At The Fair Value Of Coloplast A/S (CPH:COLO B)

Apr 26
A Look At The Fair Value Of Coloplast A/S (CPH:COLO B)

There's Reason For Concern Over Coloplast A/S' (CPH:COLO B) Price

Apr 08
There's Reason For Concern Over Coloplast A/S' (CPH:COLO B) Price

Is Coloplast (CPH:COLO B) A Risky Investment?

Mar 21
Is Coloplast (CPH:COLO B) A Risky Investment?

Estimating The Intrinsic Value Of Coloplast A/S (CPH:COLO B)

Jan 09
Estimating The Intrinsic Value Of Coloplast A/S (CPH:COLO B)

Coloplast A/S' (CPH:COLO B) Price Is Out Of Tune With Earnings

Dec 22
Coloplast A/S' (CPH:COLO B) Price Is Out Of Tune With Earnings

These 4 Measures Indicate That Coloplast (CPH:COLO B) Is Using Debt Reasonably Well

Dec 04
These 4 Measures Indicate That Coloplast (CPH:COLO B) Is Using Debt Reasonably Well

Coloplast (CPH:COLO B) Strong Profits May Be Masking Some Underlying Issues

Nov 16
Coloplast (CPH:COLO B) Strong Profits May Be Masking Some Underlying Issues

A Look At The Intrinsic Value Of Coloplast A/S (CPH:COLO B)

Sep 30
A Look At The Intrinsic Value Of Coloplast A/S (CPH:COLO B)

Is Coloplast (CPH:COLO B) A Risky Investment?

Jun 28
Is Coloplast (CPH:COLO B) A Risky Investment?

Coloplast A/S' (CPH:COLO B) Intrinsic Value Is Potentially 18% Below Its Share Price

Jun 10
Coloplast A/S' (CPH:COLO B) Intrinsic Value Is Potentially 18% Below Its Share Price

Coloplast (CPH:COLO B) Seems To Use Debt Quite Sensibly

Mar 22
Coloplast (CPH:COLO B) Seems To Use Debt Quite Sensibly

Coloplast A/S' (CPH:COLO B) Intrinsic Value Is Potentially 25% Below Its Share Price

Mar 01
Coloplast A/S' (CPH:COLO B) Intrinsic Value Is Potentially 25% Below Its Share Price

These 4 Measures Indicate That Coloplast (CPH:COLO B) Is Using Debt Reasonably Well

Dec 14
These 4 Measures Indicate That Coloplast (CPH:COLO B) Is Using Debt Reasonably Well

Coloplast's (CPH:COLO B) Upcoming Dividend Will Be Larger Than Last Year's

Nov 26
Coloplast's (CPH:COLO B) Upcoming Dividend Will Be Larger Than Last Year's

Here's Why We Think Coloplast A/S' (CPH:COLO B) CEO Compensation Looks Fair for the time being

Nov 25
Here's Why We Think Coloplast A/S' (CPH:COLO B) CEO Compensation Looks Fair for the time being

Coloplast's (CPH:COLO B) Shareholders Will Receive A Bigger Dividend Than Last Year

Nov 11
Coloplast's (CPH:COLO B) Shareholders Will Receive A Bigger Dividend Than Last Year

With EPS Growth And More, Coloplast (CPH:COLO B) Makes An Interesting Case

Oct 25
With EPS Growth And More, Coloplast (CPH:COLO B) Makes An Interesting Case

Estimating The Fair Value Of Coloplast A/S (CPH:COLO B)

Aug 26
Estimating The Fair Value Of Coloplast A/S (CPH:COLO B)

These 4 Measures Indicate That Coloplast (CPH:COLO B) Is Using Debt Reasonably Well

Jul 27
These 4 Measures Indicate That Coloplast (CPH:COLO B) Is Using Debt Reasonably Well

Here's Why We Think Coloplast (CPH:COLO B) Is Well Worth Watching

Jul 12
Here's Why We Think Coloplast (CPH:COLO B) Is Well Worth Watching

Is There An Opportunity With Coloplast A/S' (CPH:COLO B) 45% Undervaluation?

May 23
Is There An Opportunity With Coloplast A/S' (CPH:COLO B) 45% Undervaluation?

Coloplast (CPH:COLO B) Is Due To Pay A Dividend Of kr.5.00

May 08
Coloplast (CPH:COLO B) Is Due To Pay A Dividend Of kr.5.00

Coloplast (CPH:COLO B) Seems To Use Debt Rather Sparingly

Apr 13
Coloplast (CPH:COLO B) Seems To Use Debt Rather Sparingly

Here's Why I Think Coloplast (CPH:COLO B) Is An Interesting Stock

Mar 29
Here's Why I Think Coloplast (CPH:COLO B) Is An Interesting Stock

Coloplast A/S (CPH:COLO B) Shares Could Be 41% Below Their Intrinsic Value Estimate

Feb 12
Coloplast A/S (CPH:COLO B) Shares Could Be 41% Below Their Intrinsic Value Estimate

Shareholder Returns

COLO BDK Medical EquipmentDK Market
7D-1.6%-1.2%-1.4%
1Y16.8%16.8%12.2%

Return vs Industry: COLO B matched the Danish Medical Equipment industry which returned 16.8% over the past year.

Return vs Market: COLO B exceeded the Danish Market which returned 12.2% over the past year.

Price Volatility

Is COLO B's price volatile compared to industry and market?
COLO B volatility
COLO B Average Weekly Movement3.2%
Medical Equipment Industry Average Movement5.7%
Market Average Movement4.4%
10% most volatile stocks in DK Market8.3%
10% least volatile stocks in DK Market2.5%

Stable Share Price: COLO B has not had significant price volatility in the past 3 months compared to the Danish market.

Volatility Over Time: COLO B's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
195416,019Kristian Villumsenwww.coloplast.com

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand.

Coloplast A/S Fundamentals Summary

How do Coloplast's earnings and revenue compare to its market cap?
COLO B fundamental statistics
Market capDKK 199.70b
Earnings (TTM)DKK 4.97b
Revenue (TTM)DKK 26.30b

40.1x

P/E Ratio

7.6x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
COLO B income statement (TTM)
RevenueDKK 26.30b
Cost of RevenueDKK 8.54b
Gross ProfitDKK 17.76b
Other ExpensesDKK 12.79b
EarningsDKK 4.97b

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

Feb 04, 2025

Earnings per share (EPS)22.09
Gross Margin67.52%
Net Profit Margin18.88%
Debt/Equity Ratio142.3%

How did COLO B perform over the long term?

See historical performance and comparison

Dividends

2.4%

Current Dividend Yield

95%

Payout Ratio